Controversies in the management of endometrial cancer 2012


Endometrial cancer (EC) is the most frequent cancer of the female genital tract, especially in developed countries and the seventh most common cause of death from cancer in women in Western Europe. Major prognostic factors related to endometrial cancer are stage, grade, and depth of myometrial invasion and the presences of lymho-vascular space invasion. Standard treatment of EC consist of surgical and then adjuvant therapy on the basis of pathological prognostic factors. Standard surgical approach for stage I-II endomerial cancer is total hysterectomy and bilateral salpingo-oophorectomy with or without staging. Without question a comprehensive surgical staging procedure similar to that for ovarian carcinoma should be performed for non-endometrioid EC (uterine papiller serous carcinoma and clear cell adenocarcinoma) due to the aggressive clinical behavior. In contrast, there are some controversial issues in the surgical management-staging of EC and the role of ommentectomy and lymphadenectomy are the issues of current debate.

Share and Cite:

Demirkiran, F. (2012) Controversies in the management of endometrial cancer 2012. Open Journal of Obstetrics and Gynecology, 2, 373-381. doi: 10.4236/ojog.2012.24077.

Conflicts of Interest

The authors declare no conflicts of interest.


[1] McMeekin, D.S., Alektiar, K.M., and Sabbatini, P.J. (2009) Corpus: Epithelial tumors. In Barakat, R.R., Markman, M., Randall, M.E., Eds., Principles and Practice of Gynecologic Oncology. Lipponcott, Philadelphia, 683-732.
[2] Mendivil, A., Schuler, K.M. and Gehrig, P.A. (2009) Non-endometrioid adenocarcinoma of the uterine corpus: A review of selected histological subtypes. Cancer Control, 16, 46-52.
[3] Pecorelli, S. (2009) Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium. International Journal of Gynecology and Obstetrics, 105, 103-104. doi:10.1016/j.ijgo.2009.02.012
[4] Lidor, A., Ismajovich, B., Confino, E. and David, M.P. (1986) Histopathological findings in 226 women with post-menopausal uterine bleeding. Acta Obstetricia et Gynecologica Scandinavica, 65, 41-43. doi:10.3109/00016348609158227
[5] Soguktas, S., Cogendez, E., Kayatas, S.E., Asoglu, M.R, Selcuk, S. and Ertekin, A. (2012) Comparison of saline infusion sonohysterography and hysteroscopy in diagnosis of premenopausal women with abnormal uterine bleeding. European Journal of Obstetrics, Gynecology and Reproductive Biology, 161, 66-70. doi:10.1016/j.ejogrb.2011.11.022
[6] Dijkhuizen, F.P., Mol, B.W., Brolmann, H.A. and Heintz A. (2000) The accuracy of endometrial sampling in the diagnosis ofpatients with endometrial carcinoma and hyperplasia: A meta-analysis. Cancer, 89, 1765-1772. doi:10.1002/1097-0142(20001015)89:8<1765::AID-CNCR17>3.3.CO;2-6
[7] Demirkiran, F., Yavuz, E., Erenel, H., Bese, T., Arvas, M. and Sanioglu, C. (2012) Which is the best technique for endometrial sampling? Aspiration (pipelle) versus dilatetion and curettage (D&C). Archives of Gynecology and Obstetrics, in press. doi:10.1007/s00404-012-2438-8
[8] Cepni, I., Ocal, P., Erkan, S., Saricali, F.S., Akbas, H., Demirkiran, F., Idil, M. and Bese, T. (2005) Comparison of transvaginal sonography, saline infusion sonography and hysteroscopy in the evaluation of uterine cavity pathologies. The Australian & New Zealand Journal of Obstetrics & Gynecology, 45, 30-35. doi:10.1111/j.1479-828X.2005.00336.x
[9] Chan, J.K., Loizzi, V. and Youssef, M. (2003) Significance of comprehensive surgical staging in noninvasive papillary serous carcinoma of the endometrium. Gynecologic Oncology, 90, 181-188. doi:10.1016/S0090-8258(03)00195-1
[10] Boronow, R.C., Morrow, C.P., Creasman, W.T, Disaia, P.J, Silverberg, S.G., Miller, A. and Blessing, J.A. (1984). Surgical staging in endometrial cancer: Clinical-pathologic findings of a prospective study. Obstetrics and Gynecology, 63, 825-832.
[11] Creasman, W.T., Morrow, C.P, Bundy, B.N., Homesley, H.D., Graham, J.E. and Heller, P.B. (1987) Surgical pathologic spread patterns of endometrial cancer. A Gynecologic Oncology Group Study. Cancer, 60, 2035-2041. doi:10.1002/1097-0142(19901015)60:8+<2035::AID-CNCR2820601515>3.0.CO;2-8
[12] Ayhan, A., Yarali, H., Urman, B., Yuce, K., Gunalp, S. and Havlioglu, S. (1990) Comparison of clinical and surgical-pathologic staging in patients with endometrial carcinoma. Journal of Surgical Oncology, 43, 33-35. doi:10.1002/jso.2930430109
[13] Saygili, U., Kavaz, S., Altunyurt, S., Uslu, T., Koyuncuoglu, M. and Erten, O. (2001) Omentectomy, peritoneal biopsy and appendectomy in patients with clinical stage I endometrial carcinoma. International Journal of Gynecological Cancer, 11, 471-474. doi:10.1046/j.1525-1438.2001.01065.x
[14] Fujiwara, H., Saga, Y., Takahashi, K., Ohwada, M., Enomoto, A., Konno, R., Tanaka, A. and Suzuki, M. (2008) Omental metastases in clinical stage I endometrioid adenocarcinoma. International Journal Gynecological Cancer, 18, 165-167. doi:10.1111/j.1525-1438.2007.00961.x
[15] Chen, S.S. and Spiegel, G. (1991) Stage I endometrial carcinoma. Role of omental biopsy and omentectomy. Journal of Reproductive Medicine, 36, 627-629.
[16] Nieto, J.J., Gornall, R., Toms, E., Clarkson, S., Hogston, P. and Woolas, R.P. (2002) Influence of omental biopsy on adjuvant treatment field in clinical stage I endometrial carcinoma. BJOG, 109, 576-578. doi:10.1111/j.1471-0528.2002.01272.x
[17] Chen, S.S. (1995) Extrauterine spread in endometrial carcinoma clinically confined to the uterus. Gynecologic Oncology, 21, 23-31. doi:10.1016/0090-8258(85)90228-8
[18] Gehrig, P.A., Van Le, L. and Fowler Jr., W.C. (2003) The role of omentectomy during the surgical staging of uterine serous carcinoma. International Journal of Gynecological Cancer, 13, 212-215. doi:10.1046/j.1525-1438.2003.13038.x
[19] Morrow, C.P., Bundy, B.N., Kurman, R.J., Creasman, W.T., Heller, P., Homesley, H.D. and Graham, J.E. (1991) Relationship between surgical-pathological risk factors and outcome in clinical stage I and II carcinoma of the endometrium: A Gynecologic Oncology Group study. Gynecologic Oncology, 40, 55-65. doi:10.1016/0090-8258(91)90086-K
[20] Mariani, A., Dowdy, S.C., Cliby, W.A., Gostout, B.S., Jones, M.B., Wilson, T.O. and Podratz K.C. (2008) Prospective assessment of lymphatic dissemination in endometrial cancer: A paradigm shift in surgical staging. Gynecologic Oncology, 109, 11-18. doi:10.1016/j.ygyno.2008.01.023
[21] Schink, J.C., Lurain, J.R., Wallemark, C.B. and Chmiel, J.S. (1987) Tumor size in endometrial cancer: A prognostic factor forlymph nodemetastasis. Obstetrics and Gynecology, 70, 216-219.
[22] Mariani, A., Webb, M.J., Keeney, G.L., Lesnick, T.G. and Podratz, K.C. (2002) Surgical stage I endometrial cancer: Predictors of distant failure and death. Gynecologic Oncology, 87, 274-280. doi:10.1006/gyno.2002.6836
[23] Abu-Rustum, N.R., Gomez, J.D., Alektiar, K.M., Soslow, R.A., Hensley, M.L., Leitao, M.M. Jr., Gardner, G.J., Sonoda, Y., Chi, D.S. and Barakat R.R. (2009) The incidence of isolated paraaortic nodal metastasis in surgically staged endometrial cancer patients with negative pelvic lymph nodes. Gynecologic Oncology, 15, 236-238. doi:10.1016/j.ygyno.2009.07.016
[24] Fujimoto, T., Nanjyo, H., Nakamura, A., Yokoyama, Y., Takano, T., Shoji, T., Nakahara, K., Yamada, H., Mizunuma, H., Yaegashi, N., Sugiyama, T., Kurachi, H., Sato, A. and Tanaka, T. (2007) Para-aortic lymphadenectomy may improve disease-related survival in patients with multipositive pelvic lymph node stage IIIc endometrial cancer. Gynecologic Oncology, 107, 253-259. doi:10.1016/j.ygyno.2007.06.009
[25] Mariani, A., Webb, M.J., Galli, L. and Podratz, K.C. (2000) Potential therapeutic role of para-aortic lymphadenectomy in node positive endometrial cancer. Gynecologic Oncology, 76, 348-356. doi:10.1006/gyno.1999.5688
[26] Hoekstra, A.V., Kim, R.J., Small Jr., W., Rademaker, A.W., Helenowski, I.B., Singh, D.K., Schink, J.C. and Lurain, J.R. (2009) FIGO stage IIIC endometrial carcinoma: Prognostic factors and outcomes. Gynecologic Oncology, 114, 273-278. doi:10.1016/j.ygyno.2009.04.013
[27] Kilgore, L.C., Partridge, E.E., Alvarez, R.D., Austin, J.M., Shingleton, H.M., Noojin, F. and Conner W. (1995) Adenocarcinoma of the endometrium: Survival comparisons of patients with and without pelvic node sampling. Gynecologic Oncology, 56, 29-33. doi:10.1006/gyno.1995.1005
[28] Mohan, D.S., Samuels, M.A., Selim, M.A., Shalodi, A.D., Ellis, R.J., Samuels, J.R. and Yun, H.J. (1998). Long-term outcomes of therapeutic pelvic lymphadenectomy for stage I endometrial adenocarcinoma. Gynecologic Oncology, 70, 165-171. doi:10.1006/gyno.1998.5098
[29] Cragun, J.M., Havrilesky, L.J., Calingaert, B., Synan, I., Secord, A.A., Soper, J.T., Clarke-Pearson, D.L. and Berchuck, A. (2005) Retrospective analysis of selective lymphadenectomy in apparent early-stage endometrial cancer. Journal of Clinical Oncology, 23, 3668-3675. doi:10.1200/JCO.2005.04.144
[30] Trimble, E.L., Kosary, C. and Park, R.C. (1998) Lymph node sampling and survival in endometrial cancer. Gynecologic Oncology, 71, 340-343. doi:10.1006/gyno.1998.5254
[31] Chan, J.K., Cheung, M.K., Huh, W.K., Osann, K., Husain, A., Teng, N.N. and Kapp, D.S. (2006) Therapeutic role of lymph node resection in endometrioid corpus cancer: A study of 12,333 patients. Cancer, 107, 1823-1830. doi:10.1002/cncr.22185
[32] Chan, J.K., Wu, H., Cheung, M.K., Shin, J.Y., Osann, K. and Kapp, D.S. (2007) The outcomes of 27,063 women with unstaged endometrioid uterine cancer. Gynecologic Oncology, 106, 282-288. doi:10.1016/j.ygyno.2007.05.033
[33] Neubauer, N.L., Havrilesky, L.J., Calingaert, B., Bulusu, A., Bernardini, M.Q., Fleming, N.D., Bland, A.E. and Secord, A.A. (2009) The role of lymphadenectomy in the management of preoperative grade 1 endometrial carcinoma. Gynecologic Oncology, 112, 511-516. doi:10.1016/j.ygyno.2008.11.012
[34] Smith, D.C., Macdonald, O.K., Lee, C.M. and Gaffney D.K. (2008) Survival impact of lymph node dissection in endometrial adenocarcinoma: A surveillance, epidemiology, and end results analysis. International Journal of Gynecological Cancer, 18, 255-261. doi:10.1111/j.1525-1438.2007.01020.x
[35] Todo, Y., Kato, H., Kaneuchi, M., Watari, H., Takeda, M. and Sakuragi, N. (2010) Survival effect of para-aortic lymphadenectomy in endometrial cancer SEPAL study: A retrospective cohort analysis. Lancet, 375, 1165-1172. doi:10.1016/S0140-6736(09)62002-X
[36] Lowery, W.J. Gehrig, P.A., Ko, E., Secord, A.A., Chino, J. and Havrilesky, L.J. (2012) Surgical staging for endometrial cancer in the elderly—Is there a role for lymphadenectomy? Gynecologic Oncology, 126, 12-15. doi:10.1016/j.ygyno.2012.05.003
[37] Chan, J.K., Urban, R., Cheung, M.K., Shin, J.Y., Husain, A., Teng, N.N., Berek, J.S., Walker, J.L., Kapp, D.S. and Osann K. (2007) Lymphadenectomy in endometrioid uterine cancer staging: How many lymph nodes are enough? A study of 11,443 patients. Cancer, 109, 2454-2460. doi:10.1002/cncr.22727
[38] Kitchener, H., Swart, A.M., Qian, Q., Amos, C. and Par- mar, M.K. (2009) Efficacy of systematic pelvic lymphadenectomy in endometrial cancer (MRC ASTEC trial): A randomised study. Lancet, 373, 125-136. doi:10.1016/S0140-6736(08)61766-3
[39] Walker, J.L., Piedmonte, M.R., Spirtos, N.M., Eisenkop, S.M., Schlaerth, J.B., Mannel, R.S., Spiegel, G., Barakat, R., Pearl, M.L. and Sharma, S.K. (2009) Laparoscopy compared with laparotomy for comprehensive surgical staging of uterine cancer: Gynecologic Oncology Group Study LAP2. Journal of Clinical Oncology, 27, 5331-5336. doi:10.1200/JCO.2009.22.3248
[40] Lutman, C.V., Havrilesky, L.J., Cragun, J.M., Secord, A.A., Calingaert, B., Berchuck, A., Clarke-Pearson, D.L. and Soper, J.T. (2006) Pelvic lymph node count is an important prognostic variable for FIGO stage I and II endometrial carcinoma with high-risk histology. Gynecologic Oncology, 102, 92-97. doi:10.1016/j.ygyno.2005.11.032
[41] Panici, P.B., Maggioni, A., Hacker, N., Landoni, F., Grassi, R., Favalli, G., Raspagliesi, F., Giannarelli, D., Martella, L. and Mangioni, C. (2005) Systematic aortic and pelvic lymphadenectomy versus resection of bulky nodes only in optimally debulked advanced ovarian cancer: A randomized clinical trial. Journal of the National Cancer Institute, 97, 560-566. doi:10.1093/jnci/dji102
[42] ASTEC Study Group, Kitchener, H., Swart, A.M., Qian, Q. and Parmar, M. (2009) Efficacy of systematic pelvic lymphadenectomy in endometrial cancer (MRC ASTEC trial): A randomised study. Lancet, 373, 125-136. doi:10.1016/S0140-6736(08)61766-3
[43] Creasman, W.T., Mutch, D.E. and Herzog T.J. (2010) ASTEC lymphadenectomy and radiation therapy studies: Are conclusions valid? Gynecologic Oncology, 116, 293- 294. doi:10.1016/j.ygyno.2009.10.065
[44] Frumovitz, M., Slomovitz, B.M., Singh, D.K., Broaddus, R.R., Abrams, J., Sun, C.C., Bevers, M. and Bodurka, D.C. (2004) Frozen section analyses as predictors of lymphatic spread in patients with earlystage uterine cancer. Journal of the American College of Surgeons, 199, 388-393. doi:10.1016/j.jamcollsurg.2004.05.258
[45] Quinlivan, J.A., Petersen, R.W. and Nicklin, J.L. (2001) Accuracy of frozen section for the operative management of endometrial cancer. BJOG, 108, 798-803.
[46] Shim, J.U., Rose, P.G., Reale, F.R., Soto, H., Tak, W.K. and Hunter, R.E. (1992) Accuracy of frozen-section diagnosis at surgery in clinical stage I and II endometrial carcinoma. American Journal of Obstetrics & Gynecology, 166, 1335-1338.
[47] Pristauz, G., Bader, A.A., Regitnig, P., Haas, J., Winter, R. and Tamussino, K. (2009) How accurate is frozen section histology of pelvic lymph nodes in patients with endometrial cancer? Gynecologic Oncology, 115, 12-17. doi:10.1016/j.ygyno.2009.07.007
[48] Khoury-Collado, F., Glaser, G.E., Zivanovic, O., Sonoda, Y., Levine, D.A., Chi, D.S., Gemignani, M.L., Barakat, R.R. and Abu-Rustum, N.R. (2009) Improving sentinel lymph node detection rates in endometrial cancer: How many cases are needed? Gynecologic Oncology, 115, 453-455. doi:10.1016/j.ygyno.2009.08.026
[49] Mais, V., Peiretti, M., Gargiulo, T., Parodo, G., Cirronis, M.G. amd Melis, G.B. (2010) Intraoperative sentinel lymph node detectionby vital dye through laparoscopy or laparotomy in early endometrial cancer. Journal of Surgical Oncology, 101, 408-412.
[50] Querleu, D., Leblanc, E. and Castelain, B. (1991) Laparoscopic pelvic lymphadenectomy in the staging of early carcinoma of the cervix. American Journal of Obstetrics & Gynecology, 164, 579-581.
[51] Boruta II, D.M., Growdon, W.B., McCann, C.K., Garrett, L.A., del Carmen, M.G., Goodman, A. and Schorge, J.O. (2011) Evolution of surgical management of early-stage endometrial cancer. American Journal of Obstetrics & Gynecology, 205, 1-6. doi:10.1016/j.ajog.2011.06.081
[52] Mourits, M.J., Bijen, C.B., Arts, H.J., ter Brugge, H.G., van der Sijde, R., Paulsen, L., Wijma, J., Bongers, M.Y., Post, W.J., van der Zee, A.G. and de Bock, G.H. (2010) Safety of laparoscopy versus laparotomy in early-stage endometrial cancer: A randomised trial. Lancet Oncology, 11, 763-771. doi:10.1016/S1470-2045(10)70143-1
[53] Bijen, C.B., de Bock, G.H., Vermeulen, K.M., Arts, H.J., ter Brugge, H.G., van der Sijde, R., Kraayenbrink, A.A., Bongers, M.Y., van der Zee, A.G. and Mourits, M.J. (2011) Laparscopic hysterectomy is preferred over laparotomy in early endometrial cancer patients, however not cost effective in the very obese. European Journal of Cancer, 47, 2158-2165. doi:10.1016/j.ejca.2011.04.035
[54] Barnett, J.C., Havrilesky, L.J., Bondurant, A.E., Fleming, N.D., Lee, P.S., Secord, A.A., Berchuck, A. and Valea, F.A. (2011) Adverse events associated with laparoscopy vs laparotomy in the treatment of endometrial cancer. American Journal of Obstetrics & Gynecology, 205, 143. doi:10.1016/j.ajog.2011.03.012
[55] Walker, J.L., Piedmonte, M.R., Spirtos, N.M., Eisenkop, S.M., Schlaerth, J.B., Mannel, R.S., Barakat, R., Pearl, M.L. and Sharma, S.K. (2012) Recurrence and survival after random assignment to laparoscopy versus laparotomy for comprehensive surgical staging of uterine cancer: Gynecologic Oncology Group LAP2 Study. Journal of Clinical Oncology, 30, 695-700. doi:10.1200/JCO.2011.38.8645
[56] Ghezzi, F., Uccella, S., Cromi, A., Bogani, G., Robba, C., Serati, M. and Bolis, P. (2012) Lymphoceles, lymphorrhea, and lymphedema after laparoscopic and open endometrial cancer staging. Annals of Surgical Oncology, 19, 259-267. doi:10.1245/s10434-011-1854-5
[57] Diaz-Arrastia, C., Jurnalov, C., Gomez, G. and Townsend Jr., C. (2002) Laparoscopic hysterectomy using a computer-enhanced surgical robot. Surgical Endoscopy and Other Interventional Techniques, 16, 1271-1273.
[58] Paley, P.J., Veljovich, D.S., Shah, C.A., Everett, E.N., Bondurant, A.E., Drescher, C.W. and Peters III, W.A. (2011) Surgical outcomes in gynecologic oncolgy in the era of robotics: analysis of first 1000 cases. American Journal of Obstetrics & Gynecology, 204, 551. doi:10.1016/j.ajog.2011.01.059
[59] Goel, M., Zollinger, T.W. and Moore, D.H. (2011) Surgical staging of endometrial cancer: Robotic versus open technique outcomes in a contemporary single surgeon series. Journal of Robotic Surgery, 5, 109-114. doi:10.1007/s11701-010-0239-2
[60] Boggess, J.F., Gehrig, P.A., Cantrell, L., Shafer, A., Ridgway, M., Skinner, E.N. and Fowler, W.C. (2008) A comparative study of 3 surgicalmethods for hysterectomy with staging for endometrial cancer:robotic assistance, laparoscopy, laparotomy. American Journal of Obstetrics & Gynecology, 199, 360. doi:10.1016/j.ajog.2008.08.012
[61] Hoekstra, A.V., Jairam-Thodla, A., Rademaker, A., Singh, D.K., Buttin, B.M., Lurain, J.R., Schink, J.C. and Lowe, M.P. (2009) The impact of robotics on practice management of endometrial cancer: Transitioning from traditional surgery. International Journal of Medical Robotics and Computer Assisted Surgery, 5, 392-397. doi:10.1002/rcs.268

Copyright © 2024 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.